Financhill
Back

Editas Medicine Vs. Adverum Biotechnologies Industry Stock Comparison

Sell
49

EDIT
Editas Medicine

Last Price:
3.28
Seasonality Move:
21.39%
Sell
50

ADVM
Adverum Biotechnologies

Last Price:
7.91
Seasonality Move:
11.29%
Sell
49
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $3.12. The Score for EDIT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Adverum Biotechnologies (ADVM) is a Sell

Is Adverum Biotechnologies a Buy, Sell or Hold?

  • The current Adverum Biotechnologies [ADVM] share price is $7.72. The Score for ADVM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • ADVM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $3.12
    The current trend is relatively stagnant and EDIT is experiencing buying pressure, which is a positive indicator for future bullish movement.

ADVM Stock Price Chart

What is Adverum Biotechnologies's stock price today?

  • The Adverum Biotechnologies share price today is $7.72
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADVM is experiencing buying pressure, which is a positive indicator for future bullish movement.

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 45.93 Sell
Chaikin Money Flow: 1568900 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.01 - 3.39) Sell
Bollinger Bands (100): (3.3 - 4.98) Sell

ADVM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 51.43 Buy
Chaikin Money Flow: 83651 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.25 - 8.11) Buy
Bollinger Bands (100): (6.75 - 7.93) Buy

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.05 Buy
20-day SMA: 3.18 Sell
50-day SMA: 3.44 Sell
200-day SMA: 5.51 Sell
8-day EMA: 3.05 Buy
20-day EMA: 3.18 Sell
50-day EMA: 3.51 Sell
200-day EMA: 5.28 Sell

ADVM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.69 Buy
20-day SMA: 7.82 Sell
50-day SMA: 7.35 Buy
200-day SMA: 10.29 Sell
8-day EMA: 7.68 Buy
20-day EMA: 7.68 Buy
50-day EMA: 7.54 Buy
200-day EMA: 9.02 Sell

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.37 per share, and an increase next year of $0.05 per share.

Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.75 per share, and an increase next year of $0.20 per share.

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adverum Biotechnologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):